Advancing precision health discovery in a genetically diverse health system

By afschroeder • March 29, 2026

Haas R, Margolis MP, Wei A, Yamaguchi TN, Feng J, Tran T, Tozzo V, Queen KJ, Mootor MFE, Patil V, Broudy ME, Tung P, Alam S, Martinez DB, Patel Y, Caggiano C, Zeltser N, Hugh-White R, Arbet J, Shemirani R, Tian M, Thapaliya P, Eloyan L, Chen LO, Lapinska S, Ariannejad M, Lajonchere C; UCLA Precision Health Data Discovery Repository Working Group; UCLA Precision Health ATLAS Working Group; UCLA Health IT HPC Team; Regeneron Genetics Center; Kenny EE, Pasaniuc B, Bui AAT, Arboleda VA, Chang TS, Zaitlen N, Spellman PT, Boutros PC, Geschwind DH. Advancing precision health discovery in a genetically diverse health system. Cell. 2026 Mar 27:S0092-8674(26)00274-6. doi: 10.1016/j.cell.2026.03.007. Epub ahead of print. PMID: 41903539.

Tags: ancestry, Electronic health records, exome-wide association study, genetic association, genomic medicine, GLP-1 receptor agonists, health-system biobank, Hematology/Oncology, Phenome-wide association study, polygenic scores, Post Doc, Publications, semaglutide

Related Posts

A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer

Johnson ML, Smit EF, Felip E, Ramalingam SS, Ahn MJ, Tsao A, Johnson BE, Offin M, Hussein M, Dagogo-Jack I, Goldman JW, Clarke JM, Negrao[...]

Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial

Wainberg ZA, Manji GA, Bahary N, Ulahannan SV, Pant S, Spigel DR, Uboha NV, Oberstein PE, Saeed A, Beagle B, Kim JY, Wang N, Weeder[...]

Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer

Park W, Kasi A, Spira AI, Paz-Ares Rodríguez L, Herzberg BO, Pelster MS, Tolcher AW, Kuboki Y, Kitano S, Shoji H, Wang JS, Berlin JD,[...]